
Stacks & Blends
KLOW80 Australia
- HPLC tested
- 99%+ purity
- COA on file · Janoshik
Free shipping over $100 · same-day dispatch before 12pm AEST · Australia only.
Supplied strictly for in-vitro / laboratory research use only. Not for human or animal consumption. You confirm you are 18+ and purchasing for research purposes.
Product details
KLOW80 Australia. KLOW80 is a multi-component research blend supplied co-lyophilised in a single vial — BPC-157, GHK-Cu, TB-500 and KPV. It extends the GLOW-family healing blend with the melanocortin-derived tripeptide KPV. Each component is independently HPLC-content-tested by Janoshik before the batch is listed; the certificate reports per-peptide content rather than a single combined purity figure — research-honest, not marketing-shorthand.
Stocked and dispatched AU-domestic in a single 80 mg-class lyophilised vial (BPC-157 10 mg + GHK-Cu 50 mg + TB-500 10 mg + KPV 10 mg), AUD pricing. Nothing is listed without certificates on file for the components. Supplied strictly for in-vitro and laboratory research use only — not for human or animal consumption, not a therapeutic good, not TGA-approved.
- Form
- Lyophilised powder
- Composition
- BPC-157 · GHK-Cu · TB-500 · KPV
- Purity
- ≥ 99% (HPLC)
- Testing
- Janoshik — independent HPLC
- Storage
- Lyophilised −20°C; reconstituted 2–8°C
- Origin
- Dispatched AU-domestic, Australia-wide
- Use
- In-vitro / laboratory research only
KLOW80 is a formulation rather than a single chemical entity, so it has no single CAS number or molecular weight — each of its four peptides carries its own identity and sits in a distinct research literature. The blend co-presents two soft-tissue-repair peptides with a copper-peptide and an anti-inflammatory tripeptide in one vial.
BPC-157 (a synthetic pentadecapeptide) and TB-500 (the research-peptide name for thymosin β-4, the 43-residue G-actin-sequestering peptide) are both referenced across the soft-tissue-repair, wound-healing and angiogenesis research strand — reviewed for BPC-157 by Seiwerth and colleagues (Frontiers in Pharmacology, 2021) and for thymosin-β4 by Goldstein and colleagues (Expert Opinion on Biological Therapy, 2012). GHK-Cu (the copper(II)-complexed tripeptide glycyl-L-histidyl-L-lysine) sits in the copper-peptide / dermal-remodelling research strand, reviewed by Pickart and Margolina (BioMed Research International, 2015).
KPV (Lys-Pro-Val, the C-terminal tripeptide of α-MSH) sits in the melanocortin-derived anti-inflammatory research strand — studied, for example, by Kannengiesser and colleagues in murine models (Inflammatory Bowel Disease, 2008). The research rationale for the blend is to combine these four distinct pathway strands in a single reconstitution; GHK-Cu is the copper-chelate component and gives the reconstituted solution its characteristic blue tint.
Because each of the four peptides is independently HPLC-content-tested, the blend’s certificate reports the measured content of every component rather than a single combined figure — the same research-honest standard applied to the GLOW-family blends. Researchers working with multi-component vials typically record the per-component concentration achieved at reconstitution so that each pathway strand (soft-tissue repair, copper-peptide, and anti-inflammatory tripeptide) can be referenced independently within a protocol.
The information provided here is a research-reference summary only. Elite AU Peptides makes no medical, therapeutic, or human-use claim about this product or any of its components. KLOW80 is not TGA-approved, is not a therapeutic good, and is supplied strictly for in-vitro and laboratory research use only. Researchers should consult the primary peer-reviewed literature for each component’s pathway data.
Reconstitute the lyophilised KLOW80 vial with bacteriostatic water for laboratory handling. Add the diluent slowly down the vial wall and swirl gently — do not shake. The copper-peptide component (GHK-Cu) gives the reconstituted solution a characteristic blue colour, which is expected and a useful batch-consistency marker. Choose a reconstitution volume that suits the per-component concentrations your protocol requires.
Store the lyophilised powder at −20°C, desiccated and protected from light; once reconstituted, store refrigerated at 2–8°C and use within the documented research window, or aliquot and freeze to avoid repeated freeze-thaw cycles. Tamper-evident packaging; the batch label is the canonical reference for the certificates of analysis published in the lab-reports library.
Australia only. Free shipping over $100. Orders placed before 12pm AEST are dispatched the same business day from Australia.
30-day returns on unused product in original packaging, with prior approval.
- What is in the KLOW80 stack?
- KLOW80 is a multi-component research blend co-lyophilised in a single vial — BPC-157, GHK-Cu, TB-500 and KPV. Each component is independently HPLC-content-tested by Janoshik; the certificate reports per-peptide content rather than a single combined purity figure.
- How is KLOW80 different from GLOW70?
- KLOW80 extends the GLOW70 healing trio (BPC-157, GHK-Cu, TB-500) with a fourth component — the melanocortin-derived tripeptide KPV. GLOW70 is the three-peptide blend; KLOW80 is the four-peptide blend.
- Is KLOW80 a therapeutic good?
- No. KLOW80 is supplied strictly for in-vitro and laboratory research use only — not a therapeutic good, not TGA-approved, not for human or animal consumption. No medical or human-use claim is made about the blend or any component.
- Is this product third-party tested?
- Yes. Every batch is independently HPLC-tested by Janoshik, and the certificate of analysis is published on the lab-reports page.
- How should it be stored?
- Store the lyophilised powder at −20°C. Once reconstituted, keep it refrigerated at 2–8°C and use within the documented research window.
- How is it shipped?
- Dispatched AU-domestic from Australia. Free shipping over $100; orders placed before 12pm AEST are dispatched the same business day.
- What does 'research use only' mean?
- All products are supplied for in-vitro / laboratory research use only. They are not for human or animal consumption, are not therapeutic goods, and are not TGA-approved.
[ Further reading ]
KLOW80 in Australia: a four-peptide healing-blend research guideWhat KLOW80 is — a co-lyophilised research blend of BPC-157, GHK-Cu, TB-500 and KPV that extends the GLOW-family trio with an anti-inflammatory tripeptide — what each component brings, and how per-component content is HPLC-verified. A laboratory research reference for Australian researchers.
[ Certificate of analysis ]
Independently verified
Certificate of Analysis
- Lab
- Janoshik
- Batch / lot
- KLO800914
- Tested
- 24 Sep 2025
- Purity
- ≥ 99%
— Independently HPLC-tested by Janoshik. Open the certificate to verify batch KLO800914 for yourself.
Janoshik · HPLC
≥ 99%
brand standard · independently verified
[ Stacked with ]
Part of a stack
[ Related products ]
Related research peptides



Elite AU Peptides supplies research peptides and related compounds for laboratory and in-vitro research use only. Products are not therapeutic goods, are not TGA-approved, and are not for human or animal consumption. Nothing on this site constitutes medical advice or a therapeutic claim. Purchasers must be 18 years or older and are responsible for complying with all applicable laws in their jurisdiction.



